
Primary tabs
Export 85 results:
Filters: Author is Lucy Catteau
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les 5 à 17 ans en Belgique,
, Dec 2022, p.31, (2022)
COVID-19 vaccine effectiveness in adolescents: a test negative case-control study in Belgium,
, Sep 2022, (2022)
Disparities in second booster coverages and impact on COVID-19 cases and hospital admissions during summer 2022,
, Nov 2022, p.5, (2022)
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data.,
, BMC Infect Dis, 2022 Nov 11, Volume 22, Issue 1, (2022)
Guidance on interpretation of the COVID-19 vaccine impact on infections in the Sciensano weekly report,
, May 2022, p.6, (2022)
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.,
, Viruses, 2022 Apr 13, Volume 14, Issue 4, (2022)
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.,
, Viruses, 2022 Jun 16, Volume 14, Issue 6, (2022)
Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium,
, Apr 2022, (2022)
Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium.,
, PLoS One, 2022, Volume 17, Issue 6, (2022)
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij 5- tot 17-jarigen in België,
, Dec 2022, p.31, (2022)
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.,
, Vaccine, 2022 May 11, Volume 40, Issue 22, (2022)
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients,
, Archives of Public Health, Jan-12-2021, Volume 79, Issue 1, (2021)
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 en Belgique. Données jusqu’au 31 octobre 2021 inclus,
, Nov 2021, Belgium, p.53, (2021)
European antimicrobial resistance surveillance, Belgium (EARS-BE) National statistical report, data from 2019,
, Jan 2021, Brussels, Belgium, p.13, (2021)
European antimicrobial resistance surveillance for Belgium (EARS-BE) 2019 – description of main findings.,
, Feb 2021, Brussels, Belgium, p.13, (2021)
Protocol COVID-19 Surveillance in residential institutions - version 5.2,
, 02/07/2021, Brussels, Belgium, p.17, (2021)
Protocole surveillance COVID-19 dans les institutions résidentiels - version 5.2,
, 01/06/2021, p.19, (2021)
Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'".,
, Int J Antimicrob Agents, 2021 04, Volume 57, Issue 4, (2021)
Surveillance de la vaccination COVID-19 chez les professionnels de soins de santé en Belgique. Résultats intermédiaires jusqu’au 31 mai 2021 inclus,
, June 2021, Belgium, p.26, (2021)
Surveillance de la vaccination COVID-19 dans les maisons de repos et maisons de repos et de soins belges. Résultats jusqu’au 24 mars 2021.,
, Avril 2021, Belgium, p.20, (2021)
Surveillance van COVID-19 vaccinatie bij zorgverleners in België. Intermediaire resultaten tot en met 31 mei 2021,
, Juni 2021, Belgium, p.25, (2021)
Surveillance van de COVID-19 vaccinatie in Belgische woonzorgcentra. Resultaten tot 24 maart 2021.,
, 05 2021, p.20, (2021)